These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Late onset membranous nephropathy complicating donor lymphocyte infusion for leukaemia relapse after allogeneic stem cell transplantation. Lam MF; Au WY; Tse KC; Chan TM; Chan GS; Chan KW; Lai KN Am J Hematol; 2007 Apr; 82(4):327-8. PubMed ID: 17177190 [No Abstract] [Full Text] [Related]
6. Clinical utility of rituximab in chronic graft-versus-host disease. Bates JS; Engemann AM; Hammond JM Ann Pharmacother; 2009 Feb; 43(2):316-21. PubMed ID: 19193571 [TBL] [Abstract][Full Text] [Related]
7. A case of post-allogeneic haematopoietic stem cell transplantation membranous nephropathy. Sugimoto T; Tanaka Y; Sakaguchi M; Osawa N; Tanaka Y; Uzu T; Kashiwagi A Nephrol Dial Transplant; 2007 Nov; 22(11):3362-3. PubMed ID: 17602191 [No Abstract] [Full Text] [Related]
8. Delayed redistribution of CD27, CD40 and CD80 positive B cells and the impaired in vitro immunoglobulin production in patients with non-Hodgkin lymphoma after rituximab treatment as an adjuvant to autologous stem cell transplantation. Nishio M; Fujimoto K; Yamamoto S; Endo T; Sakai T; Obara M; Kumano K; Yamaguchi K; Takeda Y; Goto H; Sato N; Koizumi K; Mukai M; Koike T Br J Haematol; 2007 May; 137(4):349-54. PubMed ID: 17456057 [TBL] [Abstract][Full Text] [Related]
9. Treatment of chronic steroid-refractory graft-versus-host disease with low-dose rituximab. von Bonin M; Oelschlägel U; Radke J; Stewart M; Ehninger G; Bornhauser M; Platzbecker U Transplantation; 2008 Sep; 86(6):875-9. PubMed ID: 18813113 [TBL] [Abstract][Full Text] [Related]
13. The role of graft-versus-host disease in haematopoietic cell transplantation-associated glomerular disease. Hu SL Nephrol Dial Transplant; 2011 Jun; 26(6):2025-31. PubMed ID: 20961888 [TBL] [Abstract][Full Text] [Related]
14. Clinical applications of rituximab in allogeneic stem cell transplantation: anti-tumor and immunomodulatory effects. Ratanatharathorn V; Pavletic S; Uberti JP Cancer Treat Rev; 2009 Dec; 35(8):653-61. PubMed ID: 19682801 [TBL] [Abstract][Full Text] [Related]
15. Anti-CD20 monoclonal antibody for the treatment of refractory autoimmune haemolytic anaemia associated with idiopathic membranous nephropathy. Rossi P; Demoux AL; Granel B; Bagnères D; Bonin-Guillaume S; Frances Y Rheumatology (Oxford); 2005 Mar; 44(3):403-5. PubMed ID: 15637040 [No Abstract] [Full Text] [Related]
16. Rituximab-related late-onset neutropenia after autologous stem cell transplantation for aggressive non-Hodgkin's lymphoma. Lemieux B; Tartas S; Traulle C; Espinouse D; Thieblemont C; Bouafia F; Alhusein Q; Antal D; Salles G; Coiffier B Bone Marrow Transplant; 2004 May; 33(9):921-3. PubMed ID: 15034544 [TBL] [Abstract][Full Text] [Related]
17. [Clinical analysis of late-onset nephrotic syndrome after allogenic hematopoietic stem cell transplantation]. Luo XD; Liu QF; Ning J; Wei YQ; Fan ZP; Zhang Y; Sun J Zhonghua Yi Xue Za Zhi; 2007 Dec; 87(46):3280-3. PubMed ID: 18396625 [TBL] [Abstract][Full Text] [Related]
18. Successful therapeutic use of rituximab in refractory membranous glomerulonephritis. Cobo M; Hernández D; Rodriguez C; Pérez-Tamajón L Clin Nephrol; 2006 Jul; 66(1):54-7. PubMed ID: 16878436 [TBL] [Abstract][Full Text] [Related]
19. De novo membranous nephropathy after hematopoietic stem cell transplantation. Gupta A; Lal C; Bhowmik D Saudi J Kidney Dis Transpl; 2011 Sep; 22(5):1035-6. PubMed ID: 21912044 [No Abstract] [Full Text] [Related]
20. Prophylaxis and management of graft-versus-host disease. Ezzone S Oncology (Williston Park); 2008 Oct; 22(11 Suppl Nurse Ed):45. PubMed ID: 19856580 [No Abstract] [Full Text] [Related] [Next] [New Search]